BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 33421192)

  • 1. Gut mycobiome: The probable determinative role of fungi in IBD patients.
    Beheshti-Maal A; Shahrokh S; Ansari S; Mirsamadi ES; Yadegar A; Mirjalali H; Zali MR
    Mycoses; 2021 May; 64(5):468-476. PubMed ID: 33421192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.
    Yadav A; Yadav R; Sharma V; Dutta U
    Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.
    Sartor RB; Wu GD
    Gastroenterology; 2017 Feb; 152(2):327-339.e4. PubMed ID: 27769810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal microbiota dysbiosis in IBD.
    Sokol H; Leducq V; Aschard H; Pham HP; Jegou S; Landman C; Cohen D; Liguori G; Bourrier A; Nion-Larmurier I; Cosnes J; Seksik P; Langella P; Skurnik D; Richard ML; Beaugerie L
    Gut; 2017 Jun; 66(6):1039-1048. PubMed ID: 26843508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosa-associated microbiota dysbiosis in colitis associated cancer.
    Richard ML; Liguori G; Lamas B; Brandi G; da Costa G; Hoffmann TW; Pierluigi Di Simone M; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    Gut Microbes; 2018 Mar; 9(2):131-142. PubMed ID: 28914591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of the microbiota communities found in the various regions of the intestinal tract in healthy individuals and inflammatory bowel diseases.
    Lawal SA; Voisin A; Olof H; Bording-Jorgensen M; Armstrong H
    Front Immunol; 2023; 14():1242242. PubMed ID: 38022505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota beyond Bacteria-Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD.
    Matijašić M; Meštrović T; Paljetak HČ; Perić M; Barešić A; Verbanac D
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
    Lemoinne S; Kemgang A; Ben Belkacem K; Straube M; Jegou S; Corpechot C; ; Chazouillères O; Housset C; Sokol H
    Gut; 2020 Jan; 69(1):92-102. PubMed ID: 31003979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
    Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome.
    Fitzgerald RS; Sanderson IR; Claesson MJ
    Microb Ecol; 2021 Nov; 82(4):833-844. PubMed ID: 33666710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrative multi-omic analysis defines gut microbiota, mycobiota, and metabolic fingerprints in ulcerative colitis patients.
    Scanu M; Toto F; Petito V; Masi L; Fidaleo M; Puca P; Baldelli V; Reddel S; Vernocchi P; Pani G; Putignani L; Scaldaferri F; Del Chierico F
    Front Cell Infect Microbiol; 2024; 14():1366192. PubMed ID: 38779566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients.
    Dheer R; Davies JM; Quintero MA; Damas OM; Deshpande AR; Kerman DH; Sawyer WP; Pignac-Kobinger J; Ban Y; Fernandez I; Burgueno JF; Phillips MC; Abreu MT
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):387-402. PubMed ID: 31740421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
    Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
    Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet-Microbiota Interactions in Inflammatory Bowel Disease.
    Sugihara K; Kamada N
    Nutrients; 2021 May; 13(5):. PubMed ID: 34062869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease.
    Maronek M; Link R; Ambro L; Gardlik R
    Cells; 2020 Apr; 9(4):. PubMed ID: 32325706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota and IBD: Current knowledge and future perspectives.
    Foppa C; Rizkala T; Repici A; Hassan C; Spinelli A
    Dig Liver Dis; 2024 Jun; 56(6):911-922. PubMed ID: 38008696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art.
    Askari H; Shojaei-Zarghani S; Raeis-Abdollahi E; Jahromi HK; Abdullahi PR; Daliri K; Tajbakhsh A; Rahmati L; Safarpour AR
    Mini Rev Med Chem; 2023; 23(13):1376-1389. PubMed ID: 36111766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota as Therapeutic Targets.
    Xavier RJ
    Dig Dis; 2016; 34(5):558-65. PubMed ID: 27331403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.